Skip to main content

D89.40 vs M35.9

D89.40 (Mast cell activation, unspecified) compared with M35.9 (Systemic involvement of connective tissue, unspecified), from the official CMS tabular data. Do not report these codes together: the official tabular list marks them Excludes1.

Relationship

Conflict

Excludes1 conflict

D89.40
Mast cell activation, unspecified
M35.9
Systemic involvement of connective tissue, unspecified

Not coded here — these two are mutually exclusive.

“autoimmune disease (systemic) NOS (M35.9)”

An Excludes1 note means the two conditions cannot occur together, so the pair should not be reported for the same encounter. The sole exception is when the conditions are documented as unrelated to each other.

Source: CMS ICD-10-CM tabular instructional notes; ICD-10-CM Official Guidelines, Section I.A.12.a

Can these codes be reported together?

No — do not report together. D89.40 carries an Excludes1 note covering M35.9: “autoimmune disease (systemic) NOS (M35.9)”

Sole exception: when the two conditions are documented as unrelated to each other (ICD-10-CM Official Guidelines, Section I.A.12.a).

Side by side

D89.40Mast cell activation, unspecifiedM35.9Systemic involvement of connective tissue, unspecified
Billing statusBillableBillable
ClassificationD50-D89 — Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)M00-M99 — Diseases of the Musculoskeletal System and Connective Tissue (M00-M99)
DefinitionMast cell activation, unspecified is a billable ICD-10-CM diagnosis code (D89.40).Systemic involvement of connective tissue, unspecified is a billable ICD-10-CM diagnosis code (M35.9).
Includes
defects in the complement system
immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
sarcoidosis
Mast cell activation disorder, unspecified
autoimmune disease NOS
collagen (vascular) disease NOS
systemic autoimmune disease
systemic collagen (vascular) disease

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources